Peter Mueller

2012

In 2012, Peter Mueller earned a total compensation of $3.6M as EVP, Global R&D Chief Scientific Officer at Vertex Pharmaceuticals, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$418,296
Option Awards$2,036,301
Salary$598,980
Stock Awards$548,863
Other$12,450
Total$3,614,890

Mueller received $2M in option awards, accounting for 56% of the total pay in 2012.

Mueller also received $418.3K in non-equity incentive plan, $599K in salary, $548.9K in stock awards and $12.5K in other compensation.

Rankings

In 2012, Peter Mueller's compensation ranked 1,873rd out of 11,487 executives tracked by ExecPay. In other words, Mueller earned more than 83.7% of executives.

ClassificationRankingPercentile
All
1,873
out of 11,487
84th
Division
Manufacturing
675
out of 4,253
84th
Major group
Chemicals And Allied Products
153
out of 1,198
87th
Industry group
Drugs
86
out of 920
91st
Industry
Pharmaceutical Preparations
71
out of 700
90th
Source: SEC filing on March 28, 2014.

Mueller's colleagues

We found six more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2012.

2012

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2012

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2012

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2012

David Howton

Vertex Pharmaceuticals

Chief Legal Officer

2012

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2012

Kenneth Horton

Vertex Pharmaceuticals

Chief Legal Officer

In-depth

You may also like